insights_auto
Why is AXGN down 3,58%?
Dive Deeperchevron_right
AXGN:NASDAQ
AxoGen, Inc Common Stock
49,51 USD
arrow_downward
-3,58%(-1,84) 1D
5-ноя., 10:30:53 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
51,62 USD
High
51,85 USD
Low
49,35 USD
Mkt. cap
2,96 млд
Avg. vol.
1,78 млн
Volume
143,24 миң
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
Open
51,62 USD
High
51,85 USD
Low
49,35 USD
Mkt. cap
2,96 млд
Avg. vol.
1,78 млн
Volume
143,24 миң
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
News stories
From web sources and news partners
Investing News Network
·
21 мүнөт мурун
NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
Reuters
·
48 мүнөт мурун
Nasdaq falls at open after midterms-fueled surge as chip, data center stocks fall
Seeking Alpha
·
1 саат мурун
S&P 500 Outlook: The 2027 Rally Depends On 2028 Earnings (SP500)
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersАлачуа, Флорида, Америка Кошмо Штаттары
SectorMedical device
Industry-
Websiteaxogeninc.com